Resmed Inc Stock Performance
| RMD Stock | USD 271.63 4.58 1.72% |
ResMed has a performance score of 8 on a scale of 0 to 100. The company holds a Beta of 0.79, which implies possible diversification benefits within a given portfolio. As returns on the market increase, ResMed's returns are expected to increase less than the market. However, during the bear market, the loss of holding ResMed is expected to be smaller as well. ResMed Inc right now holds a risk of 1.42%. Please check ResMed Inc expected short fall, and the relationship between the value at risk and daily balance of power , to decide if ResMed Inc will be following its historical price patterns.
Risk-Adjusted Performance
Fair
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in ResMed Inc are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak primary indicators, ResMed may actually be approaching a critical reversion point that can send shares even higher in March 2026. ...more
Actual Historical Performance (%)
One Day Return 1.72 | Five Day Return 5.62 | Year To Date Return 10.96 | Ten Year Return 376.21 | All Time Return 40.3 K |
Forward Dividend Yield 0.0088 | Payout Ratio | Last Split Factor 2:1 | Forward Dividend Rate 2.4 | Dividend Date 2026-03-16 |
| ResMed dividend paid on 18th of December 2025 | 12/18/2025 |
1 | Bet on These 5 Low-Leverage Stocks to Avoid Industrial Volatilities | 01/15/2026 |
2 | Resmed posts Q2 FY26 earnings growth, lifts dividend | 01/29/2026 |
3 | ResMed Shares Surge After Positive Results | 01/30/2026 |
4 | ResMed Inc. RMD Shares Bought by Mediolanum International Funds Ltd | 02/02/2026 |
5 | ASX 200 Companies Across Healthcare, Software, and Wealth Services | 02/03/2026 |
6 | What can investors expect from ResMed, Cochlear and CSL shares this reporting season | 02/04/2026 |
7 | ResMed Builds Digital Sleep Apnea Ecosystem As Investors Track Valuation | 02/05/2026 |
8 | How could I turn 500 a month into 50,000 with ASX shares | 02/06/2026 |
| Begin Period Cash Flow | 238.4 M | |
| Total Cashflows From Investing Activities | -200 M |
ResMed Relative Risk vs. Return Landscape
If you would invest 24,951 in ResMed Inc on November 10, 2025 and sell it today you would earn a total of 2,212 from holding ResMed Inc or generate 8.87% return on investment over 90 days. ResMed Inc is generating 0.1469% of daily returns assuming volatility of 1.4168% on return distribution over 90 days investment horizon. In other words, 12% of stocks are less volatile than ResMed, and above 98% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
ResMed Target Price Odds to finish over Current Price
The tendency of ResMed Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 271.63 | 90 days | 271.63 | near 1 |
Based on a normal probability distribution, the odds of ResMed to move above the current price in 90 days from now is near 1 (This ResMed Inc probability density function shows the probability of ResMed Stock to fall within a particular range of prices over 90 days) .
ResMed Price Density |
| Price |
Predictive Modules for ResMed
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as ResMed Inc. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.ResMed Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. ResMed is not an exception. The market had few large corrections towards the ResMed's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold ResMed Inc, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of ResMed within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.07 | |
β | Beta against Dow Jones | 0.79 | |
σ | Overall volatility | 6.07 | |
Ir | Information ratio | 0.04 |
ResMed Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of ResMed for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for ResMed Inc can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| ResMed Inc has a strong financial position based on the latest SEC filings | |
| About 67.0% of the company shares are owned by institutional investors | |
| On 18th of December 2025 ResMed paid $ 0.6 per share dividend to its current shareholders | |
| Latest headline from fool.com.au: How could I turn 500 a month into 50,000 with ASX shares |
ResMed Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of ResMed Stock often depends not only on the future outlook of the current and potential ResMed's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. ResMed's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 147.3 M | |
| Cash And Short Term Investments | 1.2 B |
ResMed Fundamentals Growth
ResMed Stock prices reflect investors' perceptions of the future prospects and financial health of ResMed, and ResMed fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on ResMed Stock performance.
| Return On Equity | 0.26 | ||||
| Return On Asset | 0.15 | ||||
| Profit Margin | 0.28 % | ||||
| Operating Margin | 0.35 % | ||||
| Current Valuation | 37.75 B | ||||
| Shares Outstanding | 145.68 M | ||||
| Price To Earning | 73.48 X | ||||
| Price To Book | 6.06 X | ||||
| Price To Sales | 7.34 X | ||||
| Revenue | 5.15 B | ||||
| Gross Profit | 3.32 B | ||||
| EBITDA | 1.91 B | ||||
| Net Income | 1.4 B | ||||
| Cash And Equivalents | 1.21 B | ||||
| Cash Per Share | 1.87 X | ||||
| Total Debt | 851.81 M | ||||
| Debt To Equity | 0.27 % | ||||
| Current Ratio | 2.80 X | ||||
| Book Value Per Share | 43.39 X | ||||
| Cash Flow From Operations | 1.75 B | ||||
| Earnings Per Share | 10.10 X | ||||
| Market Capitalization | 39.65 B | ||||
| Total Asset | 8.17 B | ||||
| Retained Earnings | 6.08 B | ||||
| Working Capital | 2.49 B | ||||
| Current Asset | 1.42 B | ||||
| Current Liabilities | 637.99 M | ||||
About ResMed Performance
By analyzing ResMed's fundamental ratios, stakeholders can gain valuable insights into ResMed's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if ResMed has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if ResMed has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 186.20 | 162.57 | |
| Return On Tangible Assets | 0.27 | 0.28 | |
| Return On Capital Employed | 0.21 | 0.14 | |
| Return On Assets | 0.15 | 0.10 | |
| Return On Equity | 0.21 | 0.14 |
Things to note about ResMed Inc performance evaluation
Checking the ongoing alerts about ResMed for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for ResMed Inc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| ResMed Inc has a strong financial position based on the latest SEC filings | |
| About 67.0% of the company shares are owned by institutional investors | |
| On 18th of December 2025 ResMed paid $ 0.6 per share dividend to its current shareholders | |
| Latest headline from fool.com.au: How could I turn 500 a month into 50,000 with ASX shares |
- Analyzing ResMed's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether ResMed's stock is overvalued or undervalued compared to its peers.
- Examining ResMed's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating ResMed's management team can have a significant impact on its success or failure. Reviewing the track record and experience of ResMed's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of ResMed's stock. These opinions can provide insight into ResMed's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for ResMed Stock analysis
When running ResMed's price analysis, check to measure ResMed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ResMed is operating at the current time. Most of ResMed's value examination focuses on studying past and present price action to predict the probability of ResMed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ResMed's price. Additionally, you may evaluate how the addition of ResMed to your portfolios can decrease your overall portfolio volatility.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |